Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 187

    1.

    New evidence for the role of proteasome inhibitors in systemic lupus erythematosus: comment on the article by Ichikawa et al.

    Ma Y, Xu WD, Pan HF, Ye DQ.

    Arthritis Rheum. 2012 Apr;64(4):1302. doi: 10.1002/art.34407. Epub 2012 Jan 31. No abstract available.

    PMID:
    22294290
    [PubMed - in process]
    2.

    Lupus anticoagulant, but not anticardiolipin antibody, predicts adverse pregnancy outcome in patients with antiphospholipid antibodies.

    Lockshin MD, Kim M, Laskin CA, Guerra M, Branch DW, Merrill J, Petri M, Porter F, Sammaritano L, Stephenson MD, Buyon J, Salmon JE.

    Arthritis Rheum. 2012 Jan 24. doi: 10.1002/art.34402. [Epub ahead of print]

    PMID:
    22275304
    [PubMed - as supplied by publisher]
    3.

    Belimumab reduces autoantibodies, normalizes low complement, and reduces select B-cell populations in patients with systemic lupus erythematosus.

    Stohl W, Hiepe F, Latinis KM, Thomas M, Scheinberg MA, Clarke A, Aranow C, Wellborne FR, Abud-Mendoza C, Hough DR, Pineda L, Migone TS, Zhong ZJ, Freimuth WW, Chatham WW; on Behalf of the Bliss-52 and -76 Study Groups.

    Arthritis Rheum. 2012 Jan 24. doi: 10.1002/art.34400. [Epub ahead of print]

    PMID:
    22275291
    [PubMed - as supplied by publisher]
    4.

    APRIL in systemic lupus erythematosus: Essential or dispensable? Comment on the article by Jacob et al.

    Pan HF, Wang DG, Ye DQ.

    Arthritis Rheum. 2012 Jun;64(6):2052-3. doi: 10.1002/art.34388. Epub 2012 Jan 13. No abstract available.

    PMID:
    22246696
    [PubMed - in process]
    5.

    Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation.

    Nielsen CT, Østergaard O, Stener L, Iversen LV, Truedsson L, Gullstrand B, Jacobsen S, Heegaard NH.

    Arthritis Rheum. 2012 Apr;64(4):1227-36. doi: 10.1002/art.34381. Epub 2012 Jan 11.

    PMID:
    22238051
    [PubMed - in process]
    6.

    Prevalence and sociodemographic correlates of antinuclear antibodies in the United States.

    Satoh M, Chan EK, Ho LA, Rose KM, Parks CG, Cohn RD, Jusko TA, Walker NJ, Germolec DR, Whitt IZ, Crockett PW, Pauley BA, Chan JY, Ross SJ, Birnbaum LS, Zeldin DC, Miller FW.

    Arthritis Rheum. 2012 Jan 11. doi: 10.1002/art.34380. [Epub ahead of print]

    PMID:
    22237992
    [PubMed - as supplied by publisher]
    7.

    Microparticles as autoantigens: making immune complexes big.

    Pisetsky DS.

    Arthritis Rheum. 2012 Apr;64(4):958-61. doi: 10.1002/art.34377. Epub 2012 Jan 11. No abstract available.

    PMID:
    22237935
    [PubMed - in process]
    8.

    Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.

    Rovin BH, Furie R, Latinis K, Looney RJ, Fervenza FC, Sanchez-Guerrero J, Maciuca R, Zhang D, Garg JP, Brunetta P, Appel G; LUNAR Investigator Group.

    Arthritis Rheum. 2012 Apr;64(4):1215-26. doi: 10.1002/art.34359. Epub 2012 Jan 9.

    PMID:
    22231479
    [PubMed - in process]
    9.

    Brief Report: Airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: Early injury or initiating site of autoimmunity?

    Demoruelle MK, Weisman MH, Simonian PL, Lynch DA, Sachs PB, Pedraza IF, Harrington AR, Kolfenbach JR, Striebich CC, Pham QN, Strickland CD, Petersen BD, Parish MC, Derber LA, Norris JM, Holers VM, Deane KD.

    Arthritis Rheum. 2012 Jun;64(6):1756-61. doi: 10.1002/art.34344. Epub 2011 Dec 19.

    PMID:
    22183986
    [PubMed - in process]
    10.

    Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis.

    Terrier B, Geri G, Chaara W, Allenbach Y, Rosenzwajg M, Costedoat-Chalumeau N, Fouret P, Musset L, Benveniste O, Six A, Klatzmann D, Saadoun D, Cacoub P.

    Arthritis Rheum. 2012 Jun;64(6):2001-11. doi: 10.1002/art.34327. Epub 2011 Dec 6.

    PMID:
    22147555
    [PubMed - in process]
    11.

    Requirement of myeloid cell-specific Fas expression for prevention of systemic autoimmunity in mice.

    Cuda CM, Agrawal H, Misharin AV, Haines GK 3rd, Hutcheson J, Weber E, Schoenfeldt JA, Mohan C, Pope RM, Perlman H.

    Arthritis Rheum. 2012 Mar;64(3):808-20. doi: 10.1002/art.34317.

    PMID:
    22143975
    [PubMed - in process]
    12.

    Systemic autoimmunity caused by fas deficiency in macrophages: a new perspective on the first identified autoimmunity gene.

    Mountz JD, Li J, Hsu HC.

    Arthritis Rheum. 2012 Mar;64(3):609-12. doi: 10.1002/art.34321. No abstract available.

    PMID:
    22139895
    [PubMed - in process]
    13.

    Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus.

    Sreih A, Ezzeddine R, Leng L, LaChance A, Yu G, Mizue Y, Subrahmanyan L, Pons-Estel BA, Abelson AK, Gunnarsson I, Svenungsson E, Cavett J, Glenn S, Zhang L, Montgomery R, Perl A, Salmon J, Alarcón-Riquelme ME, Harley JB, Bucala R.

    Arthritis Rheum. 2011 Dec;63(12):3942-51. doi: 10.1002/art.30624.

    PMID:
    22127710
    [PubMed - indexed for MEDLINE]
    14.

    B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels.

    Ritterhouse LL, Crowe SR, Niewold TB, Merrill JT, Roberts VC, Dedeke AB, Neas BR, Thompson LF, Guthridge JM, James JA.

    Arthritis Rheum. 2011 Dec;63(12):3931-41. doi: 10.1002/art.30598.

    PMID:
    22127709
    [PubMed - indexed for MEDLINE]
    15.

    A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.

    Furie R, Petri M, Zamani O, Cervera R, Wallace DJ, Tegzová D, Sanchez-Guerrero J, Schwarting A, Merrill JT, Chatham WW, Stohl W, Ginzler EM, Hough DR, Zhong ZJ, Freimuth W, van Vollenhoven RF; BLISS-76 Study Group.

    Arthritis Rheum. 2011 Dec;63(12):3918-30. doi: 10.1002/art.30613.

    PMID:
    22127708
    [PubMed - indexed for MEDLINE]
    16.

    Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment.

    Lal P, Su Z, Holweg CT, Silverman GJ, Schwartzman S, Kelman A, Read S, Spaniolo G, Monroe JG, Behrens TW, Townsend MJ.

    Arthritis Rheum. 2011 Dec;63(12):3681-91. doi: 10.1002/art.30596.

    PMID:
    22127691
    [PubMed - indexed for MEDLINE]
    17.

    Recognizing the dense fine speckled/lens epithelium-derived growth factor/p75 pattern on HEP-2 cells: not an easy task! Comment on the article by Mariz et al.

    Bizzaro N, Tonutti E, Villalta D.

    Arthritis Rheum. 2011 Dec;63(12):4036-7; author reply 4037-8. doi: 10.1002/art.30621. No abstract available.

    PMID:
    22127717
    [PubMed - indexed for MEDLINE]
    18.

    Lupus: how much "complexity" is really (just) genetic heterogeneity?

    Crow YJ.

    Arthritis Rheum. 2011 Dec;63(12):3661-4. doi: 10.1002/art.30603. No abstract available.

    PMID:
    22127688
    [PubMed - indexed for MEDLINE]
    19.

    Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis.

    Monach PA, Tomasson G, Specks U, Stone JH, Cuthbertson D, Krischer J, Ding L, Fervenza FC, Fessler BJ, Hoffman GS, Ikle D, Kallenberg CG, Langford CA, Mueller M, Seo P, St Clair EW, Spiera R, Tchao N, Ytterberg SR, Gu YZ, Snyder RD, Merkel PA.

    Arthritis Rheum. 2011 Dec;63(12):3988-97. doi: 10.1002/art.30615.

    PMID:
    21953143
    [PubMed - indexed for MEDLINE]
    20.

    Immune responses against domain I of β(2)-glycoprotein I are driven by conformational changes: domain I of β(2)-glycoprotein I harbors a cryptic immunogenic epitope.

    de Laat B, van Berkel M, Urbanus RT, Siregar B, de Groot PG, Gebbink MF, Maas C.

    Arthritis Rheum. 2011 Dec;63(12):3960-8. doi: 10.1002/art.30633.

    PMID:
    21898342
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk